Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Pseudomonas Infections 1Neutropenia 1Gram-Positive Bacterial Infections 1Fever 1

Interventions

liposomal amphotericin B 2Vancomycin 2Cefepime 2trametinib 1pegfilgrastim 1dabrafenib 1ceftobiprole medocaril 1Tazobactam 1Piperacillin, Tazobactam Drug Combination 1Piperacillin 1Levofloxacin 1Granulocyte-Macrophage Colony-Stimulating Factor 1Filgrastim 1Ciprofloxacin 1Caspofungin 1Bevacizumab 1Anti-Bacterial Agents 1Amoxicillin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Fever × ceftobiprole medocaril × Clear all
NCT00529282 2012-08-01

A Study of Ceftobiprole in Patients With Fever and Neutropenia.

Basilea Pharmaceutica

Phase 3 Terminated
2 enrolled 4 charts

Fever, Neutropenia, Pseudomonas Infections, Gram-Positive Bacterial Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡